BACKGROUND: The Kveim-Siltzbach test has been widely used in the diagn
osis of sarcoidosis. This reactive is currently available in the autho
rs' hospitals, Previous experience with this test in the same centers
was reviewed to know its diagnostic usefulness. The present is the fir
st series described in Spain. METHODS: From 1977 to 1988 the Kveim-Sil
tzbach test was performed in 79 patients diagnosed or suspected of hav
ing sarcoidosis. The study was carried out as cooperation of the valid
ation process of sarcoid spleen suspensions (lots K12, K12 1/2, K32, K
41, K42, K42 1/2 and K50 of the Colindale antigen) prepared in the Sta
ndards Laboratory for Serological Reagents in the Royal Brompton Hospi
tal in London. RESULTS: The results of test positivity were determined
following the criteria established by Siltzbach. The global sensitivi
ty of the Kveim-Siltzbach test was 78% (CI 95% = 67.8-86.9). Positivit
y ranged from 84% in subacute sarcoidosis to 61% in chronic sarcoidosi
s (p = 0.08). Likewise, it was higher in patients with radiologic stag
e I (84%) and II (81%) with respect to stage III (62%) or the cases wi
th exclusive extrathoracic sarcoidosis (stage 0) (57%) (p = 0.11). No
association was found between the Kveim-Siltzbach test positivity and
the elevation in serum values of the angiotensin-converting enzyme (p
= 0.575).CONCLUSIONS: In the present study the Kveim-Siltzbach test sh
owed high sensitivity in the diagnosis of sarcoidosis. This fact, toge
ther with the high specificity observed in other studies, makes the te
st a very useful tool for the non-invasive diagnosis of sarcoidosis.